Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

BACKGROUND: β-adrenergic antagonists (BAAs) are used to treat cardiovascular disease such as ischemic heart disease, congestive heart failure, dysrhythmias, and hypertension. Poisoning from BAAs can lead to severe morbidity and mortality. We aimed to determine the utility of extracorporeal treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchard, Josée, Shepherd, Greene, Hoffman, Robert S., Gosselin, Sophie, Roberts, Darren M., Li, Yi, Nolin, Thomas D., Lavergne, Valéry, Ghannoum, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194226/
https://www.ncbi.nlm.nih.gov/pubmed/34112223
http://dx.doi.org/10.1186/s13054-021-03585-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194226/
https://www.ncbi.nlm.nih.gov/pubmed/34112223
http://dx.doi.org/10.1186/s13054-021-03585-7

Ejemplares similares